Status
Conditions
Treatments
About
This is a prospective, multi-center, observational, cohort study involving skilled cardiothoracic surgeons who are experienced in implanting the treatment of non-flail chest rib fractures and the use of RibFix Blu Thoracic Fixation System.
Full description
The objective of this study is to evaluate the benefits of surgical stabilization of rib fractures (SSRF) in patients with non-flail chest rib fractures using RibFix Blu Thoracic Fixation System when compared to non-surgical (analgesia and symptomatic management) treatment. The study will include up to 167 cases of non-flail chest rib fractures with 95 cases in non-surgical treatment group and 72 cases in the surgical group. Each center may enroll up to maximum 30 cases to permit the assessment of outcome across a variety investigators and clinical settings. Enrolment will be competitive among sites and closed as soon as a total of 167 cases are recruited.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Flail chest rib fractures based on radiological or clinical findings
Previous rib fractures or pulmonary problems, requiring continuous oxygen use at home pre-trauma
Presence of any serious medical issues that placed patient in generally poor conditions such that he or she could not tolerate the surgery
Chest trauma associated with severe craniocerebral injury, abdominal organ injury, severe spinal injury, limb fracture, or pelvic fracture requiring long-term bed rest
Has serious medical disease that is a contraindication for general anesthesia, such as cerebral infarction, myocardial infarction and hemorrhagic syndrome
Any contraindications listed in the manufacturer's Instruction to use for RibFix Blu Thoracic Fixation System as per below:
Is known to be pregnant
Is a prisoner, known alcohol or drug user or mentally incompetent or unable to understand what participation in this study entails.
Participation in another surgical intervention that may influence any of the outcome parameters.
167 participants in 2 patient groups
Loading...
Central trial contact
Irene Chong
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal